title: Leprosy in a renal transplant recipient: review of the literature.
abstract: A 52-year-old male underwent living-related renal transplantation. He received prednisolone, azathioprine, and cyclosporine as immunosuppression protocol. Eleven years after transplantation, he developed pyrexia with multiple nodular lesions on his limbs, trunk, and face. Skin biopsy and smears showed the presence of numerous acid-fast bacilli with 5% sulfuric acid indicative of Mycobacterium leprae. He was initiated on multidrug therapy (MDT) including dapsone, clofazimine, and rifampicin. After 2 years of MDT, he developed new multiple erythematous, tender subcutaneous nodules in crops over his face and upper limbs. Skin biopsies and histopathological examination confirmed the diagnosis of type 2 lepra reaction or erythema nodosa leprosum. He was managed with an increase in the dose of prednisolone and thalidomide. He was continued on MDT.
authors: Department of Nephrology, Nizam's Institute of Medical Sciences, Hyderabad, Andhra Pradesh, India. swarnamalli@hotmail.com
authors: S
authors: S
authors: Guditi
authors: R
authors: R
authors: Ram
authors: K M
authors: KM
authors: Ismal
authors: M
authors: M
authors: Sahay
authors: K V
authors: KV
authors: Dakshinamurthy
authors: N
authors: N
authors: Girish
authors: N
authors: N
authors: Prasad
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects*; D015440:Leprosy, Lepromatous / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology*; D008297:Male; D008875:Middle Aged; D009166:Mycobacterium leprae / Q000187:drug effects / Q000302:isolation & purification*
chemical_list: D000995:Antitubercular Agents